Lifeboat Foundation

Another medical miracle from Israel…

Our morning routine could be appended to something like “breakfast, stretching, sit on a medical examiner, shower, then commute.” If we are speaking seriously, we don’t always get to our morning stretches, but a quick medical exam could be on the morning agenda. We would wager that a portion of our readers are poised for that exam as they read this article. The examiner could come in the form of a toilet seat. This IoT throne is the next device you didn’t know you needed because it can take measurements to detect signs of heart failure every time you take a load off.

Tracking heart failure is not just one test, it is a buttload of tests. Continuous monitoring is difficult although tools exist for each test. It is unreasonable to expect all the at-risk people to sit at a blood pressure machine, inside a ballistocardiograph, with an oximeter on their fingers three times per day. Getting people to browse Hackaday on their phones after lunch is less of a struggle. When the robots overthrow us, this will definitely be held against us.

Continue reading “Toilet Seat Could Save Your Ass” »

The United States should devote substantially more resources to nuclear fusion research and build an ambitious prototype fusion power plant, according to a new report.

The report is the work of the National Academies of Sciences, Engineering, and Medicine. Its conclusion: it’s more important than ever for the U.S. and the world to explore roads to practical fusion power.

Are tired-out cells what make people old? A new generation of drugs is designed to wipe them out.

An international team of researchers, from Imperial College London and the University of Melbourne in Australia, has demonstrated a new AI system that can effectively predict survival rates from ovarian cancer better than any current conventional method available to doctors.

Cell replacement may play an increasing role in alleviating the symptoms such as movement problems and memory loss of Parkinson’s disease (PD), researchers say. (Photo: iStockphoto)

The team will transplant 2 million cells into the spines of the patients, who will then go through rehabilitation and be monitored for a year. Photo: Handout.

The Longevity Therapeutics Summit was focused on therapeutics that target aging, rather than basic research or theory.

This was the first year for the Longevity Therapeutics Summit in San Francisco, California. Ably organized by Hanson Wade, with John Lewis, CEO of Oisín Biotechnologies, as program chair, the conference focused on senolytics for senescent cell clearance, big data and AI in finding new drugs (“in silico” testing), delivery systems for therapeutics like senolytics, TORC1 drugs, and biomarkers of aging, and the challenges of clinical trial development and FDA approval.

The conference featured a smorgasbord of cutting-edge longevity research, and, as the name implies, the general focus was on therapeutics that target aging, rather than basic research or theory.

Continue reading “A Report from the Longevity Therapeutics Summit” »

An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that people with type 1 diabetes have to give themselves every day. About the size of a blueberry, the capsule contains a small needle made of compressed insulin, which is injected after the capsule reaches the stomach. In tests in animals, the researchers showed that they could deliver enough insulin to lower blood sugar to levels comparable to those produced by injections given through skin. They also demonstrated that the device can be adapted to deliver other protein drugs.

Capsule that releases insulin in the stomach could replace injections for patients with type 1 diabetes.